Camp4 Therapeutics Corp financial data

Symbol
CAMP on Nasdaq
Industry
Pharmaceutical Preparations
Location
One Kendall Square, Building 1400 West, 3 Rd Floor, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Return On Equity 54.8 % +18.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 20.2M shares
Common Stock, Shares, Outstanding 20.1M shares +4273%
Common Stock, Value, Issued 2K USD +100%
Weighted Average Number of Shares Outstanding, Basic 557K shares +39.2%
Weighted Average Number of Shares Outstanding, Diluted 557K shares +39.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 9.7M USD -1.19%
General and Administrative Expense 3.81M USD +32.9%
Operating Income (Loss) -13.5M USD -9.55%
Nonoperating Income (Expense) 32K USD -95%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -51.8M USD -5.07%
Earnings Per Share, Basic -24.2 USD/shares +17.2%
Earnings Per Share, Diluted -24.2 USD/shares +17.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 64M USD +66.9%
Accounts Receivable, after Allowance for Credit Loss, Current 1M USD
Other Assets, Current 211K USD -13.9%
Assets, Current 66.4M USD +65.9%
Property, Plant and Equipment, Net 3.86M USD -19.6%
Operating Lease, Right-of-Use Asset 6.02M USD -22.5%
Assets 78.3M USD +42.5%
Accounts Payable, Current 1.21M USD +16.1%
Employee-related Liabilities, Current 3.11M USD +60.6%
Accrued Liabilities, Current 4.83M USD +46.4%
Contract with Customer, Liability, Current 385K USD
Liabilities, Current 9.6M USD +22.9%
Operating Lease, Liability, Noncurrent 5.49M USD -35.3%
Other Liabilities, Noncurrent 2K USD 0%
Liabilities 15.2M USD -8.26%
Retained Earnings (Accumulated Deficit) -212M USD -32.4%
Stockholders' Equity Attributable to Parent 63.1M USD
Liabilities and Equity 78.3M USD +42.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 175M shares -16.7%
Common Stock, Shares, Issued 20.2M shares +1865%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 65.7M USD +64.1%
Deferred Tax Assets, Valuation Allowance 64.9M USD +30.9%
Deferred Tax Assets, Gross 66.6M USD +28.7%
Operating Lease, Liability 8.49M USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -13.5M USD -15.3%
Lessee, Operating Lease, Liability, to be Paid 9.26M USD
Property, Plant and Equipment, Gross 10.1M USD +8.46%
Operating Lease, Liability, Current 2.99M USD +10.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.56M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 3.46M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 769K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.98M USD
Deferred Tax Assets, Operating Loss Carryforwards 27.7M USD +46.1%
Preferred Stock, Shares Authorized 25M shares
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 263K USD
Operating Lease, Payments 770K USD +1.99%
Additional Paid in Capital 275M USD +659%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 1.59M USD +120%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares